CA1119540A - Anti-tumor substance and preparation thereof - Google Patents

Anti-tumor substance and preparation thereof

Info

Publication number
CA1119540A
CA1119540A CA000307116A CA307116A CA1119540A CA 1119540 A CA1119540 A CA 1119540A CA 000307116 A CA000307116 A CA 000307116A CA 307116 A CA307116 A CA 307116A CA 1119540 A CA1119540 A CA 1119540A
Authority
CA
Canada
Prior art keywords
substance
antitumor
prepared
culture broth
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000307116A
Other languages
English (en)
French (fr)
Inventor
Shigeo Ogino
Noboru Yoshida
Takao Kiyohara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Application granted granted Critical
Publication of CA1119540A publication Critical patent/CA1119540A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
CA000307116A 1977-07-11 1978-07-10 Anti-tumor substance and preparation thereof Expired CA1119540A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP83129/77 1977-07-11
JP52083129A JPS58318B2 (ja) 1977-07-11 1977-07-11 制癌性物質の製造方法

Publications (1)

Publication Number Publication Date
CA1119540A true CA1119540A (en) 1982-03-09

Family

ID=13793578

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000307116A Expired CA1119540A (en) 1977-07-11 1978-07-10 Anti-tumor substance and preparation thereof

Country Status (9)

Country Link
US (1) US4209507A (cg-RX-API-DMAC7.html)
JP (1) JPS58318B2 (cg-RX-API-DMAC7.html)
CA (1) CA1119540A (cg-RX-API-DMAC7.html)
CH (1) CH639133A5 (cg-RX-API-DMAC7.html)
DE (1) DE2829975A1 (cg-RX-API-DMAC7.html)
FR (1) FR2397193B1 (cg-RX-API-DMAC7.html)
GB (1) GB2000680B (cg-RX-API-DMAC7.html)
IT (1) IT1099569B (cg-RX-API-DMAC7.html)
SE (1) SE7807645L (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5635989A (en) * 1979-08-16 1981-04-08 Sumitomo Chem Co Ltd Preparation of carcinostatic substance
DE3031152A1 (de) * 1979-08-24 1981-03-19 Toyama Chemical Co. Ltd., Tokyo Carcinostatische substanzen, verfahren zur herstellung derselben und mittel mit einem gehalt derselben
EP0157544A3 (en) * 1984-03-29 1987-08-05 Takeda Chemical Industries, Ltd. Antibiotics, their production and use
US4751182A (en) * 1984-04-20 1988-06-14 Wisconsin Alumni Research Foundation Process for preparing L-carnitine from DL-carnitine
US5075109A (en) * 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US6024983A (en) * 1986-10-24 2000-02-15 Southern Research Institute Composition for delivering bioactive agents for immune response and its preparation
JPH0259056A (ja) * 1988-08-25 1990-02-28 Midori Anzen Kk 空気清浄機
CH677325A5 (cg-RX-API-DMAC7.html) * 1989-04-28 1991-05-15 Asea Brown Boveri

Also Published As

Publication number Publication date
JPS58318B2 (ja) 1983-01-06
FR2397193A1 (cg-RX-API-DMAC7.html) 1979-02-09
FR2397193B1 (cg-RX-API-DMAC7.html) 1981-07-24
SE7807645L (sv) 1979-01-12
IT7825570A0 (it) 1978-07-11
US4209507A (en) 1980-06-24
GB2000680A (en) 1979-01-17
CH639133A5 (de) 1983-10-31
GB2000680B (en) 1982-04-07
IT1099569B (it) 1985-09-18
JPS5420196A (en) 1979-02-15
DE2829975A1 (de) 1979-01-25

Similar Documents

Publication Publication Date Title
JP2873340B2 (ja) 抗生物質tan―1057,その製造法および用途
CA1119540A (en) Anti-tumor substance and preparation thereof
KR870001373B1 (ko) 항생물질 BMG 162-aF2의 제조방법
EP0459367B1 (en) Method for preparing an antitumor dextran
US3985869A (en) Dental caries-inducing microorganism cells lytic enzyme
CA1282779C (en) Polysaccharide ron substance, production of the same and use of the same
US4656037A (en) SPF-100 and process for the preparation thereof
US5565342A (en) Process for producing polysaccharide ron substance with a synthetase
EP0084334B1 (en) Polysaccharide substance, process for the production of same, pharmaceutical compositions containing the same and their use as medicaments
EP0024206A2 (en) Antitumor substance, composition comprising it and process for preparing said substance
CA1202585A (en) Process for preparing substance having carcinostatic and immunostimulating activity
US4477437A (en) Substances having carcinostatic and immunostimulating activity
EP0084333B1 (en) Polysaccharide substance, process for the production of same, pharmaceutical compositions containing the same and their use as medicaments
EP0173228A2 (en) Polysaccharide rin substance, production of the same and use of the same
JPS6041483A (ja) 難消化性多糖類の分解能を有する菌体培養液の製造法
US3792160A (en) Method of treating inflammation and composition therefor
WO1996039155A1 (en) Immunopotentiator
US3794564A (en) Process for the production of anticapsin
JPS627918B2 (cg-RX-API-DMAC7.html)
US3691014A (en) Method for producing protease
JPS6344128B2 (cg-RX-API-DMAC7.html)
JPS5912274B2 (ja) α−1.3−グルコシド結合を分解する酵素の製造法
JPH0367048B2 (cg-RX-API-DMAC7.html)
JPS6261036B2 (cg-RX-API-DMAC7.html)
JPS6216426A (ja) 抗腫瘍性成分spf−10及びその製法

Legal Events

Date Code Title Description
MKEX Expiry